US 10006031
Antisense composition and method for treating muscle atrophy
granted A61KA61K31/675A61K47/645
Quick answer
US patent 10006031 (Antisense composition and method for treating muscle atrophy) held by Sarepta Therapeutics, Inc. expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/675, A61K47/645, A61P, A61P21/00